Loading clinical trials...
Loading clinical trials...
Role of SAMITAL® in Prevention and Treatment of Oral Mucositis in Patients Treated With Chemo-radiation (CT/RT)for Head-and-neck Squamous Cell Carcinomas. A Double-blind, Phase 2 Placebo Controlled, Randomized Trial.
Conditions
Interventions
SAMITAL®
Placebo sachets
Locations
1
Italy
Radiotherapy Department, Istituto Oncologico Veneto
Padua, Italy
Start Date
December 1, 2012
Primary Completion Date
December 1, 2016
Completion Date
January 1, 2018
Last Updated
September 13, 2018
NCT05853692
NCT07040969
NCT06968520
NCT06390176
NCT07467759
NCT07287826
Lead Sponsor
Istituto Oncologico Veneto IRCCS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions